The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation

Brief Summary

The aim of the study is to compare the use of dexmedetomidine + ketamine with dexmedetomidine + placebo for sedation in ICU patients in terms of safety and efficacy

Intervention / Treatment

  • Drug: Dexmedetomidine
  • Drug: Ketamine

Condition or Disease

  • ICU Patients
  • Sedation

Phase

Study Design

Study type: Interventional
Status: Unknown status
Study results: No Results Available
Age: 18 Years to 80 Years   (Adult, Older Adult)
Enrollment: 394 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Sep 16, 2019
Primary Completion: Sep 16, 2021
Completion Date: Dec 30, 2021
Study First Posted: Sep 20, 2019
Results First Posted: Aug 31, 2020
Last Updated: Feb 20, 2020

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Location

Eligibility Criteria

Sex: All
Minimum Age: 18
Maximum Age: 80

More Details

NCT Number: NCT04096768
Other IDs: FA2.2016.R2.21/Jun/2019
Study URL: https://ClinicalTrials.gov/show/NCT04096768
Last updated: Jun 17, 2022